1SXP — SCHOTT Pharma AG & Co KgaA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for SCHOTT Pharma AG & Co KgaA, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	R2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.2	30.6	28.4	26.9	27
Net Total Accounts Receivable
Net Total Receivables	187	385	285	399	466
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	302	555	468	584	681
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	334	517	638	723	786
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	740	1,197	1,232	1,438	1,599
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	244	323	351	435	454
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	322	489	541	651	707
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	418	707	690	787	892
Total Liabilities & Shareholders' Equity	740	1,197	1,232	1,438	1,599
Total Common Shares Outstanding